RMD resmed.com: Multiplikator Forward P/S
The future EV/Revenue multiple demonstrates the stability of ResMed Inc. (RMD) against a backdrop of a neutral geopolitical climate and secured supply chains. Cloud telemetry creates a closed-loop sleep therapy ecosystem, ensuring customer retention. Meanwhile, the 5.00 metric determines the status of the valuation parameter. The profile is completed by the implementation of ESG standards through plastic reduction and factory energy efficiency, which strengthens the manufacturer's environmental image.
Rincian metrik lan analitis perusahaan ResMed Corporation (RMD)
- rega saiki lan proyeksi nilai saham:
- data kapitalisasi saham perusahaan:
- statistik nilai buku emiten:
- indikator total utang lan likuiditas perusahaan:
Total Utang marang Modal ResMed Inc.|RMD - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas ResMed Inc.|RMD - Utang perusahaan|Utang marang nilai buku ResMed Corporation|RMD - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan ResMed|Likuiditas cepet resmed.com
- rincian asil keuangan lan kelipatan valuasi:
RMD - Bathi resik taunan|Bathi mangsa ngarep ResMed Inc.|RMD - Pangali P/E|Pangali Forward P/E ResMed Corp|RMD - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan ResMed Corporation|RMD - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan ResMed|RMD - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan resmed.com|RMD - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep ResMed Inc.
- indikator volume dodolan lan pendapatan:
Ringkesan analitik perusahaan:ResMed (RMD)
The forward P/S ratio determines the valuation of ResMed Inc. relative to expected revenue, isolating the fundamental trend from short-term market noise. Analyzing the forward P/S history allows for an assessment of capitalization efficiency, accounting for currency risks and the export balance. This ratio reflects the premium for the technological leadership of ResMed Inc., driven by patent protection for CPAP systems and the high switching costs for clinics transitioning to alternative solutions.
Pesaing wigati
Multiplikator Forward P/S BSX (Boston Scientific Corporation)|Edwards (EW) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|OmniPod - Multiplikator Forward P/S|ZBH (Zimmer Biomet Holdings) - Kapitalisasi marang prakiraan pendapatan|COO: Multiplikator Forward P/S|ALGN - Rasio kapitalisasi marang dodolan sing dikarepake|GMED (Globus Medical) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan TransMedics Group Inc (TMDX)|Multiplikator Forward P/S ATEC|Multiplikator Forward P/S Artivion Corp (AORT)|Rasio rega marang prakiraan pendapatan Enovis Corporation ENOV|integralife.com - Rasio rega marang prakiraan pendapatan|ESTA: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan BBNX (Beta Bionics, Inc.)|IRMD: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Embecta Health (EMBC)|Rasio rega marang prakiraan pendapatan Tandem Diabetes Care|AXGN - Prakiraan rega marang pendapatan|Multiplikator forward rega marang pendapatan SIBN (SI-BONE)|Multiplikator Forward P/S Orthofix Medical (OFIX)|Multiplikator Forward P/S BVS (Bioventus Corp)|Rasio kapitalisasi marang dodolan sing dikarepake OrthoPediatrics Corp (KIDS)|TMCI - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan SRTA|Carlsmed (CARL) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan RxSight Inc|CLPT (ClearPoint Neuro Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Stereotaxis Corporation STXS|Rasio rega marang prakiraan pendapatan Neuronetics, Inc. (STIM)|sightsciences.com - Kapitalisasi marang prakiraan pendapatan|Orchestra BioMed, Inc. - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake ANIK (Anika Therapeutics Inc.)|NSPR - Rasio rega marang prakiraan pendapatan|Rega forward marang dodolan ZJYL (Jin Medical International)|VANI: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Xtant Medical (XTNT)|Rasio rega marang prakiraan pendapatan NeuroOne Medical Technologies Corporation|Modular Med (MODD) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Myomo, Inc (MYO)|Multiplikator forward rega marang pendapatan Envoy Medical Inc COCH|Multiplikator Forward P/S VVOS (Vivos Therapeutics)|envveno.com (NVNO) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|SINTX Technologies - Multiplikator Forward P/S|TNON (Tenon Medical Inc.) - Kapitalisasi marang prakiraan pendapatan|LFWD (ReWalk Robotics Ltd) - Multiplikator forward rega marang pendapatan|Autonomix Medical - Rega forward marang dodolan|IVF (INVO Fertility Inc) - Multiplikator Forward P/S|bonebiologics.com (BBLG) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Axonics (AXNX)|BIOLASE Inc. - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S DYNT (Dynatronics)|FNA - Multiplikator forward rega marang pendapatan|INVO: Multiplikator forward rega marang pendapatan
